Germany, Feb. 24 -- Germany based Nuvisan ICB GmbH has secured contract from Universitatsklinikum Aachen AoR for Research laboratory services - Implementation of a CRISPRi-based CROP-seq screening for single-cell resolution of fibrosis-relevant signaling pathways. The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....